Clinical Scorecard: Impact of Antipsychotic Drug Administration in Individuals with Dementia: A Systematic Review and Meta-Analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
Antipsychotic drugs (APDs) are used to manage BPSD but are associated with increased mortality and other adverse effects, including stroke and pneumonia.
Target Population
Care Setting
Key Highlights
APD use is linked to a 32% increased risk of mortality in PwD.
Both typical and atypical APDs show similar risk elevation for mortality.
Higher mortality risks are observed in community-dwelling individuals.
Limited evidence suggests increased risks for stroke, pneumonia, and hip fractures, but further research is needed.
Non-pharmacological interventions, such as behavioral therapy and environmental modifications, are recommended as first-line treatment.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Conduct regular medication reviews and monitor for adverse effects, including vital signs and cognitive function.
Risks
Patient & Prescribing Data
APDs may provide modest benefits for aggression and psychosis but carry significant safety concerns, necessitating careful consideration.
Clinical Best Practices
Perform individualized risk-benefit evaluations before prescribing APDs, considering non-pharmacological options.
Reassess ongoing therapy regularly to ensure continued appropriateness.
Monitor for potential adverse effects throughout treatment, including cognitive decline and physical health.
